Your browser doesn't support javascript.
loading
Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure.
Yazaki, Mayu; Nabeta, Takeru; Inomata, Takayuki; Maemura, Kenji; Ooki, Takumi; Fujita, Teppei; Iida, Yuichiro; Ikeda, Yuki; Ishii, Shunsuke; Naruke, Takashi; Ako, Junya.
Afiliación
  • Yazaki M; Department of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara Japan.
  • Nabeta T; Department of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara Japan.
  • Inomata T; Department of Cardiovascular Medicine, Kitasato University Kitasato Institute Hospital Tokyo Japan.
  • Maemura K; Department of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara Japan.
  • Ooki T; Department of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara Japan.
  • Fujita T; Department of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara Japan.
  • Iida Y; Department of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara Japan.
  • Ikeda Y; Department of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara Japan.
  • Ishii S; Department of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara Japan.
  • Naruke T; Department of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara Japan.
  • Ako J; Department of Cardiovascular Medicine, Kitasato University School of Medicine Sagamihara Japan.
Circ Rep ; 2(1): 51-59, 2019 Dec 14.
Article en En | MEDLINE | ID: mdl-33693174

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Circ Rep Año: 2019 Tipo del documento: Article Pais de publicación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Circ Rep Año: 2019 Tipo del documento: Article Pais de publicación: Japón